drugset
drugset / Trial / NCT04349696

Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)

NCT04349696 ↗

Phase 4 Completed 16 enrolled Orient Europharma Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This clinical trial is designed to assess the effect of hepatic impairment on the pharmacokinetic and pharmacodynamic of glufast tablets 10 mg.

Timeline

Start
2014-02-11
Primary completion
2018-04
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitiglinide Small molecule 10 mg Oral

Indications

liver disorder type 2 diabetes mellitus